Alphagan patent ruling
Allergan's lawsuit for induced infringement against Alcon and Bausch & Lomb was properly dismissed because the two companies' ANDAs for brimonidine did not seek FDA approval for uses claimed in two Allergan patents, U.S. appeals court rules March 28 (1"The Pink Sheet" Jan. 27, p. 18)...
You may also be interested in...
Neurontin generics will have to overcome limitations in the bulk drug supply in addition to Pfizer's patent defenses, Pfizer CEO Henry McKinnell told a Jan. 22 earnings conference call
Sun Pharma’s founder and MD shares with Scrip his views on some key big picture issues, including leveraging pandemic-related regulatory experience for urgently needed products, expectations in the US market, the outlook for M&A, and the potential of e-pharmacies in India.
India is allowing importers and manufacturers of certain devices – for whom new licensing requirements came into effect on 1 January – to continue marketing their products for six months if they have already applied for a license. See what Rajiv Nath from the Association of Indian Medical Device Industry (AiMeD) said about it here.